These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20596251)

  • 1. Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes.
    Abu El-Asrar AM; Struyf S; Opdenakker G; Van Damme J; Geboes K
    Mol Vis; 2010 Jun; 16():1098-107. PubMed ID: 20596251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes.
    Abu El-Asrar AM; Struyf S; Verbeke H; Van Damme J; Geboes K
    Acta Ophthalmol; 2011 May; 89(3):222-8. PubMed ID: 19764917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.
    Chen LL; Zhu J; Schumacher J; Wei C; Ramdas L; Prieto VG; Jimenez A; Velasco MA; Tripp SR; Andtbacka RHI; Gouw L; Rodgers GM; Zhang L; Chan BK; Cassidy PB; Benjamin RS; Leachman SA; Frazier ML
    PLoS One; 2017; 12(9):e0184154. PubMed ID: 28880927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes.
    Abu El-Asrar AM; Missotten L; Geboes K
    Clin Exp Ophthalmol; 2010 Jan; 38(1):57-64; quiz 87. PubMed ID: 20447102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes.
    El-Asrar AM; Missotten L; Geboes K
    Br J Ophthalmol; 2008 Nov; 92(11):1534-9. PubMed ID: 18952655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell factor is a potent endothelial permeability factor.
    Kim JY; Choi JS; Song SH; Im JE; Kim JM; Kim K; Kwon S; Shin HK; Joo CK; Lee BH; Suh W
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1459-67. PubMed ID: 24790137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg1 prevents vascular intimal hyperplasia involved by SDF-1α/CXCR4, SCF/c-kit and FKN/CX3CR1 axes in a rat balloon injury.
    Hu A; Shuai Z; Liu J; Huang B; Luo Y; Deng J; Liu J; Yu L; Li L; Xu S
    J Ethnopharmacol; 2020 Oct; 260():113046. PubMed ID: 32504784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular precursors in developing human retina.
    Hasegawa T; McLeod DS; Prow T; Merges C; Grebe R; Lutty GA
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2178-92. PubMed ID: 18436851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes.
    Abu El-Asrar AM; Missotten L; Geboes K
    Acta Ophthalmol; 2012 Mar; 90(2):e84-9. PubMed ID: 22103573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.
    Abu El-Asrar AM; Missotten L; Geboes K
    Br J Ophthalmol; 2007 Jun; 91(6):822-6. PubMed ID: 17229797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
    Kobayashi Y; Yoshida S; Zhou Y; Nakama T; Ishikawa K; Arima M; Nakao S; Sassa Y; Takeda A; Hisatomi T; Ikeda Y; Matsuda A; Sonoda KH; Ishibashi T
    Mol Vis; 2016; 22():436-45. PubMed ID: 27186070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
    Abu El-Asrar AM; Van den Steen PE; Al-Amro SA; Missotten L; Opdenakker G; Geboes K
    Int Ophthalmol; 2007 Feb; 27(1):11-22. PubMed ID: 17375263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
    Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
    Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit.
    Lennartsson J; Shivakrupa R; Linnekin D
    J Biol Chem; 2004 Oct; 279(43):44544-53. PubMed ID: 15308671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.
    El-Asrar AM; Missotten L; Geboes K
    Mol Vis; 2011 Feb; 17():508-18. PubMed ID: 21365018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy.
    Kase S; Saito W; Ohgami K; Yoshida K; Furudate N; Saito A; Yokoi M; Kase M; Ohno S
    Br J Ophthalmol; 2007 Oct; 91(10):1376-8. PubMed ID: 17522145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.